his and hers glp 1 Novo Nordisk Drops Hims & Hers: Inside the Compounded GLP-1 Crisis Hims & Hers says it

It helps combat occasional tiredness, supporting sustained energy and mental focus for your daily activities

Data Availability Statement The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request

Data on the number of people in the US taking glucagon-like peptide-1 medications, both to reduce obesity and to help control diabetes, show a somewhat stable trend

By Distribution Channel)- Global Market Size, Share, Growth, Trends, Statistics Analysis Report, By Region And Segment Forecasts 20242032 Market Overview The glucagon-like peptide 1 (GLP-1) agonist market size was valued at USD 10.8 Billion in 2023 and is expected to reach a market size of USD 21.2 Billion by 2032 at a CAGR of 7.8%

Finally, we screened reference lists from relevant published studies

BioMed Res Int (2021) 2021:3361309